directly associated with BRONJ. 4 Periodontal disease (PD) is strongly related with BRONJ, 5 and these two conditions have a common characteristic; both PD and BRONJ have a proinflammatory characteristics. 4, 6 Chronic treatment with BF leads cellular toxicity in various cell types [7] [8] [9] [10] through an increase in the synthesis of cytokines. 9 The BF bind to hydroxyapatite irreversibly, and the high time of contact between BF and BF-toxicity-susceptive cells increases toxic effects of BF in these cells and increases the number of dead cells. 11 Furthermore, there is a reduction in the phagocytotic activity of macrophages induced by BF, 9 and the elimination of injured cells can be compromised and lead to high oxidative stress. 12 Then, infiltration of neutrophils can occur leading to high oxidative stress and bone necrosis. 4 It has been reported that periodontium possesses basal levels of proinflammatory markers 13 ; however, chronic BF treatment augments cytokine levels in crevicular fluid. 5 A previous study suggested the relationship between inflammation and BRONJ, 4 so if is it correct, why are not all patients treated with BF present BRONJ?
Mammalian has a complex antioxidant system responsible for homeostasis of free radicals. 13 The reduction in oxidative stress attenuates the PD, reduces cytokine overproduction and inflammatory cells migration, and decreases osteocyte loss. 1 However, the relationship between chronic BF and the expression of inflammatory and pro-oxidant markers in rats "not periodontally compromised" is not known.
Therefore, the objective of this study was to evaluate the changes in inflammatory markers and oxidative stress in healthy periodontal tissue of rats chronically treated with ZA. 
| MATERIALS AND METHODS

| Histological and histochemical reaction
Histological slides (4 lm) were deparaffinized, dehydrated, and stained by conventional hematoxylin-eosin (H&E) technique or toluidine blue (0.1% for 60 seconds) (mast cell evaluation).
| Immunohistochemical protocol
We performed an immunohistochemical assay for CD68, TNF-a, IL1b, inducible nitric oxide synthase (iNOS), and nuclear factor kappa B (NF-kB 
| MPO assay
The gingiva of the lower first right molar of the rats (n = 6/group) was homogenized in NaPO 4 
| Malondialdehyde assay (MDA)
The gingiva of first right inferior molar of rats (n = 6/group) was homogenized in KCl (1.15%) buffer (100 mg of tissue/1 mL). Then, the samples were centrifuged (4580 g, 15 minutes). We added 100 lL of 7% sodium dodecyl sulfate (SDS) to Eppendorf tubes and incubated the tubes in a water bath (37°C, 30 minutes). Thiobarbituric acid 0.6% (200 lL) was added, and the samples were placed in a water bath at 100°C for 50 minutes. After cooling in ice (5 minutes), we added 100 lL of n-butanol, vortexed (30 seconds), and centrifuged for 20 minutes (580 g, 4°C).
The supernatant of samples (200 lL) and the standard were pipetted in microtiter plates, and the absorbance was measured at 535 nm. The results are expressed as nmol/mg of tissue and reported as mean AE SE. 16 
| Glutathione (GSH)
The gingiva of first right inferior molar of rats (n = 6/group) was homogenized in EDTA 0.02M buffer (100 mg of tissue/1 mL). Then, we transferred 100 lL of the homogenate into different Eppendorf tubes, added 80 lL of H 2 O and 20 lL of 50% trichloroacetic acid, and vortexed (30 seconds).
The sample was centrifuged (3000 rpm, 15 minutes), and 100 lL of supernatant was transferred to other Eppendorf tubes along with 100 lL of 0.4 M Tris-EDTA (pH = 8.9) and 10 lL of 0.01 M DTNB (acid 5 0 ,5 0 -dithio-bis(2-nitrobenzoic acid)) and was vortexed (40 seconds). 
| DISCUSSION
BF treatment leads some cellular types die or interfere in their metabolism. [7] [8] [9] [10] The cellular toxicity increases in parallel to cytokines overexpression, 17 and the fibroblasts of periodontium are not an exception. 18 Gingival tissue produced high levels of proinflammatory mediators in response to BF, as shown in this study.
The chronic infusion of ZA increases the number of inflammatory cells and TNF-a and IL-1b levels significantly. This alteration was observed in periodontal cells and in gingiva of the rats treated with ZA with an augmentation of neutrophils. The MPO activity was also significantly enhanced in gingiva of ZA-treated groups likely because TNF-a and IL-1b are important in the chemotaxis of neutrophils. 19 The induction of some chemokines in a TNF-a-dependent and IL1b-dependent manner contributes to an augment of neutrophils and damages locally. 14, 15 Neutrophils produce high levels of reactive oxygen species (ROS) that contribute to more inflammatory cell migration. Additionally, ZA impairs neutrophil function and reduces neutrophil survival in vitro. When these cells die (after phagocytosis or after their short cell cycle), they liberate ROS, causing vasodilatation. 7 Additionally, a recent research demonstrated that treatment of gingival fibroblasts with ZA decreases the cell viability, especially when these cells were incubated with IL-1b. 20 This way involves increasing cyclooxygenase 2 (COX-2) and prostaglandin E2 (PGE2) expression and leads to neutrophil migration and augment of oxidative stress.
14,15
The augmentation of proinflammatory commonly leads rises in oxidative stress markers, but in this study, it was accompanied by an increase in GSH levels preventing an increase in MDA formation.
Bagan 21 showed that cancer patients treated with intravascular BF have increased oxidized glutathione, but not GSH itself. Nevertheless, these patients have some malignancies that increase the production of ROS per se.
22
Complex antioxidants agents maintain homeostasis of aerobic metabolism. Because the pro-oxidant agents did not exceed the antioxidant systems, there are compensatory mechanisms.
23
BRONJ is a condition directly associated with proinflammatory (TNF-a, IL-1b, IL-17) markers and iNOS activity, 24 and it appears that macrophages and the nuclear activity of NF-kB are necessary for the pathogenesis of this condition 4, 17 In this study, an increase in the nuclear expression of NF-kB and number of rats showing mononuclear CD68-positive cells were not shown in the "healthy periodon-
tium," but we demonstrated the rise of GSH levels.
Overproduction of antioxidants, such as GSH, represses cell apoptosis 24 and NF-kB activation. 25 So, the upregulated compensatory antioxidant system can protect the periodontal cells which are suffering damage 12 by ZA-induced cytokines. 17 BF enhance proinflammatory cytokines (TNF-a and IL-1b), but these drugs increase the synthesis of important antioxidant molecules. 18 Periodontal cells treated with BF produce more OPG (osteoprotegerin) 18 that is directly associated with GSH protection activity (21) . Additionally, osteoblasts treated with risedronate increase other antioxidant proteins as Hsp90 (22) . Hsp90 is an important antioxidant molecule that decreases ROS formation and peroxidation (23) .
In eukaryotic cells, Hsp90 is linked to GSH, and it is necessary the cleavage of two proteins to release GSH (24) .
Nevertheless, the metabolism of ROS in bone is complex, occasionally paradoxical and need many studies to comprise the rule of Thus, we showed that chronic infusion of ZA in rats can lead to inflammatory alteration with an increase in proinflammatory markers in gingiva and periodontium. Additionally, we found a significant increase in compensatory GSH levels in gingiva of ZA-treated groups. These data contribute to the hypothesis that the ZA can lead an immune inflammatory disruption and to facilitate the installation of BRONJ. 
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